Skip to main content
SpringerLink
Log in

Nirmatrelvir-ritonavir (Paxlovid) Access, Use, and Eligibility Among Adults with COVID-19 in Los Angeles County: The LA Pandemic Surveillance Cohort Study

  • Concise Research Report
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. U.S. Food and Drug Administration. Emergency Use Authorization (EUA) for Nirmatrelvir-ritonavir (nirmatrelvir and ritonavir). FDA; 2023, https://www.fda.gov/media/155049/download.

  2. Shah MM, Joyce B, Plumb ID, et al. Nirmatrelvir-ritonavir associated with decreased hospitalization rate among adults with COVID-19 — United States, April–September 2022. Am J Transplant. 2023;23(1):150-155. https://doi.org/10.1016/j.ajt.2022.12.004.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lam CN, Nicholas W, Torre ADL, et al. Factors associated with parents’ willingness to vaccinate their children against COVID-19: the LA pandemic surveillance cohort study. AIMSPH. 2022;9(3):482-489. https://doi.org/10.3934/publichealth.2022033.

    Article  Google Scholar 

  4. Centers for Disease Control and Prevention (CDC). Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals. Atlanta, GA: US Department of Health and Human Services, CDC; 2023. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html.

  5. Zargar AH, Kalra S, K M PK, et al. Rising cost of insulin: a deterrent to compliance in patients with diabetes mellitus. Diabetes Metab Syndr: Clin Res Rev. 2022;16(8):102528. https://doi.org/10.1016/j.dsx.2022.102528.

    Article  CAS  Google Scholar 

  6. Boehmer TK, Koumans EH, Skillen EL, et al. Racial and ethnic disparities in outpatient treatment of COVID-19 ― United States, January–July 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1359–1365. https://doi.org/10.15585/mmwr.mm7143a2.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

We acknowledge funding from the Conrad N. Hilton Foundation, Office of the President University of Southern California, Los Angeles County Department of Public Health, the US Centers for Disease Control and Prevention, the Keck School of Medicine at USC, the Keck Family Foundation, and several individual donors.

Author information

Authors and Affiliations

  1. Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    Ryan Lee BA, Jennifer B. Unger PhD, Shirin Emma Herzig BA & Howard Hu MD, MPH, ScD

  2. Sol Price School of Public Policy, University of Southern California, Los Angeles, CA, USA

    Neeraj Sood PhD

  3. Department of Emergency Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    Chun Nok Lam PhD, MPH

Authors
  1. Ryan Lee BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neeraj Sood PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chun Nok Lam PhD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jennifer B. Unger PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shirin Emma Herzig BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Howard Hu MD, MPH, ScD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryan Lee BA.

Ethics declarations

Conflict of Interest:

The authors declare that they do not have a conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, R., Sood, N., Lam, C.N. et al. Nirmatrelvir-ritonavir (Paxlovid) Access, Use, and Eligibility Among Adults with COVID-19 in Los Angeles County: The LA Pandemic Surveillance Cohort Study. J GEN INTERN MED 39, 1081–1083 (2024). https://doi.org/10.1007/s11606-023-08591-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-023-08591-9

Search

Navigation